Particle Therapy Market (Therapy: Proton Therapy, and Heavy Ion Therapy; and Services: Cyclotrons, Synchrotrons, and Synchrocyclotrons) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
Particle Therapy Market – Scope of Report
TMR’s report on the global particle therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global particle therapy market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global particle therapy market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the particle therapy market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global particle therapy market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global particle therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global particle therapy market.
The report delves into the competitive landscape of the global particle therapy market. Key players operating in the global particle therapy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global particle therapy market profiled in this report.
Key Questions Answered in Global particle therapy Market Report
- What is the sales/revenue generated by particle therapy across all regions during the forecast period?
- What are the opportunities in the global particle therapy market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
The comprehensive report on the global particle therapy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global particle therapy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global particle therapy market.
- 1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Particle Therapy Market
- 4. Market Overview
- 4.1. Introduction
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Particle Therapy Market Analysis and Forecast, 2017 - 2031
- 4.4.1. Market Revenue Projections (US$ Mn)
- 5. Key Insights
- 5.1. Technological Advancements
- 5.2. Reimbursement Scenario
- 5.3. Particle Therapy Facilities In Clinical Operations
- 5.4. Average Prices, by Region, 2022
- 5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long Term Impact)
- 6. Global Particle Therapy Market Analysis and Forecast, By Therapy
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Therapy, 2017 - 2031
- 6.3.1. Proton Therapy
- 6.3.2. Heavy Ion Therapy (carbon therapy, He, pion)
- 6.4. Market Attractiveness Analysis, By Therapy
- 7. Global Particle Therapy Market Analysis and Forecast, By Application
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Application, 2017 - 2031
- 7.3.1. Pediatric Cancer
- 7.3.2. Lung Cancer
- 7.3.3. Bladder Cancer
- 7.3.4. Brain & Spinal Cord Tumors (BSCT)
- 7.3.5. Breast Cancer
- 7.3.6. Gastrointestinal (GI) Cancers
- 7.3.7. Hepatocellular Carcinoma (HCC)
- 7.3.8. Head & Neck Cancers (HNC)
- 7.3.9. Others
- 7.4. Market Attractiveness Analysis, By Application
- 8. Global Particle Therapy Market Analysis and Forecast, By Services
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by Services, 2017 - 2031
- 8.3.1. Cyclotrons
- 8.3.2. Synchrotrons
- 8.3.3. Synchrocyclotrons
- 8.4. Market Attractiveness Analysis, By Services
- 9. Global Particle Therapy Market Analysis and Forecast, By End-user
- 9.1. Introduction & Definition
- 9.2. Key Findings / Developments
- 9.3. Market Value Forecast, by End-user, 2017 - 2031
- 9.3.1. Hospitals
- 9.3.2. Academic & Research Centers
- 9.4. Market Attractiveness Analysis, By End-user
- 10. Global Particle Therapy Market Analysis and Forecast, By Region
- 10.1. Key Findings
- 10.2. Market Value Forecast, by Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Rest of the World
- 10.3. Market Attractiveness Analysis, By Region
- 11. North America Particle Therapy Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast, by Therapy, 2017 - 2031
- 11.2.1. Proton Therapy
- 11.2.2. Heavy Ion Therapy (carbon therapy, He, pion)
- 11.3. Market Value Forecast, by Application, 2017 - 2031
- 11.3.1. Pediatric Cancer
- 11.3.2. Lung Cancer
- 11.3.3. Bladder Cancer
- 11.3.4. Brain & Spinal Cord Tumors (BSCT)
- 11.3.5. Breast Cancer
- 11.3.6. Gastrointestinal (GI) Cancers
- 11.3.7. Hepatocellular Carcinoma (HCC)
- 11.3.8. Head & Neck Cancers (HNC)
- 11.3.9. Others
- 11.4. Market Value Forecast, by Services, 2017 - 2031
- 11.4.1. Cyclotrons
- 11.4.2. Synchrotrons
- 11.4.3. Synchrocyclotrons
- 11.5. Market Value Forecast, by End-user, 2017 - 2031
- 11.5.1. Hospitals
- 11.5.2. Academic & Research Centers
- 11.6. Market Value Forecast, by Country, 2017 - 2031
- 11.6.1. U.S.
- 11.6.2. Canada
- 11.7. Market Attractiveness Analysis
- 11.7.1. By Therapy
- 11.7.2. By Application
- 11.7.3. By Services
- 11.7.4. By End-user
- 11.7.5. By Country
- 12. Europe Particle Therapy Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast, by Therapy, 2017 - 2031
- 12.2.1. Proton Therapy
- 12.2.2. Heavy Ion Therapy (carbon therapy, He, pion)
- 12.3. Market Value Forecast, by Application, 2017 - 2031
- 12.3.1. Pediatric Cancer
- 12.3.2. Lung Cancer
- 12.3.3. Bladder Cancer
- 12.3.4. Brain & Spinal Cord Tumors (BSCT)
- 12.3.5. Breast Cancer
- 12.3.6. Gastrointestinal (GI) Cancers
- 12.3.7. Hepatocellular Carcinoma (HCC)
- 12.3.8. Head & Neck Cancers (HNC)
- 12.3.9. Others
- 12.4. Market Value Forecast, by Services, 2017 - 2031
- 12.4.1. Cyclotrons
- 12.4.2. Synchrotrons
- 12.4.3. Synchrocyclotrons
- 12.5. Market Value Forecast, by End-user, 2017 - 2031
- 12.5.1. Hospitals
- 12.5.2. Academic & Research Centers
- 12.6. Market Value Forecast, by Country/Sub-region, 2017 - 2031
- 12.6.1. Germany
- 12.6.2. U.K.
- 12.6.3. France
- 12.6.4. Spain
- 12.6.5. Italy
- 12.6.6. Rest of Europe
- 12.7. Market Attractiveness Analysis
- 12.7.1. By Therapy
- 12.7.2. By Application
- 12.7.3. By Services
- 12.7.4. By End-user
- 12.7.5. By Country/Sub-region
- 13. Asia Pacific Particle Therapy Market Analysis and Forecast
- 13.1. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast, by Therapy, 2017 - 2031
- 13.2.1. Proton Therapy
- 13.2.2. Heavy Ion Therapy (carbon therapy, He, pion)
- 13.3. Market Value Forecast, by Application, 2017 - 2031
- 13.3.1. Pediatric Cancer
- 13.3.2. Lung Cancer
- 13.3.3. Bladder Cancer
- 13.3.4. Brain & Spinal Cord Tumors (BSCT)
- 13.3.5. Breast Cancer
- 13.3.6. Gastrointestinal (GI) Cancers
- 13.3.7. Hepatocellular Carcinoma (HCC)
- 13.3.8. Head & Neck Cancers (HNC)
- 13.3.9. Others
- 13.4. Market Value Forecast, by Services, 2017 - 2031
- 13.4.1. Cyclotrons
- 13.4.2. Synchrotrons
- 13.4.3. Synchrocyclotrons
- 13.5. Market Value Forecast, by End-user, 2017 - 2031
- 13.5.1. Hospitals
- 13.5.2. Academic & Research Centers
- 13.6. Market Value Forecast, by Country/Sub-region, 2017 - 2031
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
- 13.7. Market Attractiveness Analysis
- 13.7.1. By Therapy
- 13.7.2. By Application
- 13.7.3. By Services
- 13.7.4. By End-user
- 13.7.5. By Country/Sub-region
- 14. Rest of the World Particle Therapy Market Analysis and Forecast
- 14.1. Introduction
- 14.1.1. Key Findings
- 14.2. Market Value Forecast, by Therapy, 2017 - 2031
- 14.2.1. Proton Therapy
- 14.2.2. Heavy Ion Therapy (carbon therapy, He, pion)
- 14.3. Market Value Forecast, by Application, 2017 - 2031
- 14.3.1. Pediatric Cancer
- 14.3.2. Lung Cancer
- 14.3.3. Bladder Cancer
- 14.3.4. Brain & Spinal Cord Tumors (BSCT)
- 14.3.5. Breast Cancer
- 14.3.6. Gastrointestinal (GI) Cancers
- 14.3.7. Hepatocellular Carcinoma (HCC)
- 14.3.8. Head & Neck Cancers (HNC)
- 14.3.9. Others
- 14.4. Market Value Forecast, by Services, 2017 - 2031
- 14.4.1. Cyclotrons
- 14.4.2. Synchrotrons
- 14.4.3. Synchrocyclotrons
- 14.5. Market Value Forecast, by End-user, 2017 - 2031
- 14.5.1. Hospitals
- 14.5.2. Academic & Research Centers
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Therapy
- 14.6.2. By Application
- 14.6.3. By Services
- 14.6.4. By End-user
- 15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company, 2022
- 15.3. Company Profiles
- 15.3.1. Advanced Oncotherapy plc
- 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.1.2. Product Portfolio
- 15.3.1.3. SWOT Analysis
- 15.3.1.4. Strategic Overview
- 15.3.2. Danfysik A/S
- 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.2.2. Product Portfolio
- 15.3.2.3. SWOT Analysis
- 15.3.2.4. Strategic Overview
- 15.3.3. Hitachi, Ltd.
- 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.3.2. Product Portfolio
- 15.3.3.3. SWOT Analysis
- 15.3.3.4. Strategic Overview
- 15.3.4. IBA Worldwide
- 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.4.2. Product Portfolio
- 15.3.4.3. SWOT Analysis
- 15.3.4.4. Strategic Overview
- 15.3.5. Mevion Medical Systems, Inc.
- 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.5.2. Product Portfolio
- 15.3.5.3. SWOT Analysis
- 15.3.5.4. Strategic Overview
- 15.3.6. Optivus Proton Therapy, Inc.
- 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.6.2. Product Portfolio
- 15.3.6.3. SWOT Analysis
- 15.3.6.4. Strategic Overview
- 15.3.7. Protom International, Inc.
- 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.7.2. Product Portfolio
- 15.3.7.3. SWOT Analysis
- 15.3.7.4. Strategic Overview
- 15.3.8. Provision Healthcare
- 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.8.2. Product Portfolio
- 15.3.8.3. SWOT Analysis
- 15.3.8.4. Strategic Overview
- 15.3.9. Varian Medical Systems, Inc.
- 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.9.2. Product Portfolio
- 15.3.9.3. SWOT Analysis
- 15.3.9.4. Strategic Overview
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook